Open Access<p>Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study</p>
Author(s) -
Charleen D. Adams
Publication year - 2020
Publication title -
clinical interventions in aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 76
eISSN - 1178-1998
pISSN - 1176-9092
DOI - 10.2147/cia.s239350
Subject(s) - mendelian randomization , medicine , disease , glutamine , randomization , alzheimer's disease , oncology , genetics , gene , clinical trial , genetic variants , genotype , amino acid , biology
Alzheimer's disease is a devastating neurodegenerative disorder. Its worldwide prevalence is over 24 million and is expected to double by 2040. Finding ways to prevent its cognitive decline is urgent.